Why Not Big Pharma’s Route
42:48–43:28 · 40s
Lane contrasts his path with drug development, arguing decades and billions haven’t cracked ALS, so he focused on leveraging innate biology instead.
42:48–43:28 · 40s
Lane contrasts his path with drug development, arguing decades and billions haven’t cracked ALS, so he focused on leveraging innate biology instead.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.